Finally, these results may not be generalizable to non-OSTRICH institutions. Additional research is warranted.
1
Standard treatment for fNMSCs requires biopsy for pathological confirmation, followed by excision. 2, 3 Excision can lead to a pathological diagnosis of no residual carcinoma (NRC) due to no identifiable carcinoma within the excisional specimen. This situation can occur owing to wound healing in the specimen clearing the carcinoma or to the original biopsy shaving off the entire lesion. This study assesses the utility of excising fNMSCs according to age, with the hypothesis that the indolent nature of fNMSCs and the high NRC rate, coupled with increasing age-related all-cause mortality, should cause the surgeon to counsel patients differently. Such counseling may prevent surgery among elderly patients (>90 years) who may never see a benefit from fNMSC excision.
Methods | This study was approved by the Richard L. Roudebush Veterans Affairs Medical Center institutional review board. We identified 440 patients older than 40 years of age who received standard excision for biopsy-proven fNMSC between January 1, 2013, and December 31, 2015. Patient demographics and carcinoma characteristics were analyzed. 2,3 Overall survival and age-specific estimated survival from time of excision were assessed. χ 2 Testing was used to compare groups, and odds ratios were calculated using logistic regression. Statistical significance was set at P ≤ .05, and statistical analysis was performed with SPSS software (IBM). The proportion of cases of basal cell carcinoma with NRC to cases of squamous cell carcinoma with NRC did not change as a function of age by decade. Although 50 patients (11.3%) died, no death was due to the spread of NMSC. The survival rate decreased by decade of life ( Figure) , with the lowest survival rate (52%) among patients who were older than 90 years and who also had the highest NRC rate (20 [51.2%]) (Table) .
Discussion | Currently, age is not a consideration in the treatment of fNMSCs. Patients, whether they are 40 or 90 years of age, are treated the same for small, minimally morbid, nonlethal NMSCs. Two specific issues should guide the treatment of fNMSCs above the eighth decade of life, with the benefit weighed against the estimated life span of the patient. The first issue is the likelihood of NRC after lesion excision, which is demonstrated here to occur in older patients at a similar rate as the rate in multiple previously studied populations.
4-6 More than a third of patients older than 80 years (and more than half of those >90 years) had no carcinoma present after biopsy when evaluated histologically after excision. This finding indicates that a large minority of patients would not have required either a primary excision or reexcision. The second issue is patient longevity. Actuarial tables can estimate with some certainty the relative probability of death, but, to our knowledge, this study is the first to indicate that disease-specific survival is not affected by the excision of small fNMSCs. No patient in the study died of fNMSC. In more than half of the cases of fNMSC excision in patients older than 90 years, death occurred within 1 year. These small fNMSCs would never have caused a problem. When coupled with an NRC rate of 50%, a strong argument can be made for a watchful-waiting approach for the amenable nonagenarian. These 2 issues should be discussed with the patient on a case-by-case basis so that patient comfort and outcomes can be maximized. Future studies are needed to investigate if a watchful-waiting approach is cost-effective and has higher patient satisfaction than surgical excision in this elderly population. 30  24  24  10  18  29  198  194  162  83  124  196  155  145  117  52  88  149  148  133  104  47  70  139  39  28  17  3  4 and meta-analysis, electrotherapy and acupuncture could potentially reduce and delay consumption of opioids, which are used for pain relief after total knee arthroplasty. However, despite being very interested, we would like to address a few concerns regarding this article. First, the authors used a random-effects model to analyze cases where the number of studies were less than 5 or substantial heterogeneity was found (I 2 statistic greater than 50%). Nevertheless, the number of studies for the evidence of cryotherapy for postoperative (day 1) pain management (in eFigure 2 in the Supplement 1 ) was 7, and the I 2 statistic was 40%. In addition, we found that a random-effects model was also used to pool the outcomes. Similarly, the random-effects model was also used in the subgroup sensitivity analyses (section 16.1.2 OTHER in eFigure 10 and section 16.18.2 Secondary in eFigure 20 in the Supplement 1 ).
We think it would be better to choose a fixed-effects model to do the analysis. Otherwise, it would be helpful to explain why the random-effects model is preferred in these cases. Second, the authors searched the publications with language restrictions (only publications written in English were included), but this can be regarded as a limitation because exclusively relying on English-language publications may not be representative of all the evidence available.
2 Based on the search criteria of the study by Tedesco et al, 1 unpublished studies may have been missed. This is another limitation that could lead to a bias and could even influence the results. Finally, the authors noted, "Two reviewers independently extracted the data from selected articles" in the Data Extraction and Synthesis section of the Abstract. However, in the Data Analysis and Synthesis section of the Methods, the author wrote, "Three of us (D.T., D.G., and K.R.D.) independently extracted the data from included articles." This is a minor inconsistency that needs to be reviewed to avoid confusion.
